Computational screening of inhibitors for HIV-1 integrase using a receptor based pharmacophore model

  • Jaganatharaja J
  • Gowthaman R
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

The HIV (human immunodeficiency virus) integrase has a crucial role in viral replication. Moreover, it has no cellular homologue in humans. Hence, it is considered as an attractive drug target. Many inhibitors against the integrase protein has been designed and discussed. The Y-3 inhibitor (4-acetyl amino-5-hydroxy naphthalene - 2, 7- disulfonic acid) is already known to inhibit HIV-1 integrase. However, it is not suitable as a drug like candidate due to its high cyto-toxicity. In this report, a pharmacophore model for HIV integrase is described using the already known Y-3 inhibitor binding site. Fourteen compounds chemically related to the Y-3 inhibitor were generated using the described pharmacophore model and reported. Subsequent computational analysis showed that these compounds have interactions with the Y3 binding site and their possible utility as an integrase inhibitor is discussed.

Cite

CITATION STYLE

APA

Jaganatharaja, J., & Gowthaman, R. (2012). Computational screening of inhibitors for HIV-1 integrase using a receptor based pharmacophore model. Bioinformation, 1(4), 112–117. https://doi.org/10.6026/97320630001112

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free